1. miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia
- Author
-
Francesco Boccalatte, Anna Ranghetti, Fabio Ciceri, Eric R. Lechman, Jose Manuel Garcia-Manteiga, Bernhard Gentner, Luigi Naldini, Silvia Nucera, Maurilio Ponzoni, Tiziana Plati, Fabrizio Benedicenti, Eugenio Montini, Andrea Calabria, Alice Giustacchini, Davide Cittaro, Cristiana Fanciullo, John E. Dick, Nucera, Silvia, Giustacchini, Alice, Boccalatte, Francesco, Calabria, Andrea, Fanciullo, Cristiana, Plati, Tiziana, Ranghetti, Anna, Garcia Manteiga, Jose, Cittaro, Davide, Benedicenti, Fabrizio, Lechman, Eric R., Dick, John E., Ponzoni, Maurilio, Ciceri, Fabio, Montini, Eugenio, Gentner, Bernhard, and Naldini, Luigi
- Subjects
0301 basic medicine ,Cancer Research ,Cellular differentiation ,Apoptosis ,Biology ,Mice ,03 medical and health sciences ,Downregulation and upregulation ,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma ,microRNA ,medicine ,Animals ,Humans ,Progenitor cell ,B cell ,Regulation of gene expression ,Cell Cycle ,Hematopoietic Stem Cell Transplantation ,Cell Differentiation ,Neoplasms, Experimental ,Cell Biology ,Cell cycle ,Hematopoietic Stem Cells ,medicine.disease ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,B-cell leukemia ,Cancer research ,Tumor Suppressor Protein p53 ,Signal Transduction - Abstract
MicroRNA (miRNA)-126 is a known regulator of hematopoietic stem cell quiescence. We engineered murine hematopoiesis to express miRNA-126 across all differentiation stages. Thirty percent of mice developed monoclonal B cell leukemia, which was prevented or regressed when a tetracycline-repressible miRNA-126 cassette was switched off. Regression was accompanied by upregulation of cell-cycle regulators and B cell differentiation genes, and downregulation of oncogenic signaling pathways. Expression of dominant-negative p53 delayed blast clearance upon miRNA-126 switch-off, highlighting the relevance of p53 inhibition in miRNA-126 addiction. Forced miRNA-126 expression in mouse and human progenitors reduced p53 transcriptional activity through regulation of multiple p53-related targets. miRNA-126 is highly expressed in a subset of human B-ALL, and antagonizing miRNA-126 in ALL xenograft models triggered apoptosis and reduced disease burden.
- Published
- 2016
- Full Text
- View/download PDF